Home
>
National Drug Code (NDC)
>
Theo-24
Theo-24 - 50474-200-01 - (theophylline anhydrous)
Drug Information of Theo-24
| Product NDC: | 50474-200 |
| Proprietary Name: | Theo-24 |
| Non Proprietary Name: | theophylline anhydrous |
| Active Ingredient(s): | 200 mg/1 & nbsp; theophylline anhydrous |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Theo-24
| Product NDC: | 50474-200 |
| Labeler Name: | UCB, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA087943 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980120 |
Package Information of Theo-24
| Package NDC: | 50474-200-01 |
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-200-01) |
NDC Information of Theo-24
| NDC Code | 50474-200-01 |
| Proprietary Name | Theo-24 |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-200-01) |
| Product NDC | 50474-200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | theophylline anhydrous |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19980120 |
| Marketing Category Name | ANDA |
| Labeler Name | UCB, Inc. |
| Substance Name | THEOPHYLLINE ANHYDROUS |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
